Rigel Pharmaceuticals Inc (RIGL)
1.11
-0.03
(-2.63%)
USD |
NASDAQ |
Apr 17, 16:00
1.11
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Cash from Investing (Quarterly): -6.874M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.874M |
| September 30, 2023 | -1.17M |
| June 30, 2023 | 2.97M |
| March 31, 2023 | 0.777M |
| December 31, 2022 | 18.60M |
| September 30, 2022 | 10.46M |
| June 30, 2022 | 21.10M |
| March 31, 2022 | 22.63M |
| December 31, 2021 | 6.488M |
| September 30, 2021 | -44.40M |
| June 30, 2021 | -49.66M |
| March 31, 2021 | 7.532M |
| December 31, 2020 | 8.711M |
| September 30, 2020 | 19.53M |
| June 30, 2020 | -5.234M |
| March 31, 2020 | 24.46M |
| December 31, 2019 | -7.617M |
| September 30, 2019 | -0.294M |
| June 30, 2019 | -14.67M |
| March 31, 2019 | -1.073M |
| December 31, 2018 | 2.093M |
| September 30, 2018 | 15.86M |
| June 30, 2018 | -16.20M |
| March 31, 2018 | 23.22M |
| December 31, 2017 | -35.24M |
| Date | Value |
|---|---|
| September 30, 2017 | 7.561M |
| June 30, 2017 | 8.356M |
| March 31, 2017 | -0.15M |
| December 31, 2016 | 2.111M |
| September 30, 2016 | 10.39M |
| June 30, 2016 | 19.15M |
| March 31, 2016 | -6.771M |
| December 31, 2015 | 12.75M |
| September 30, 2015 | 30.65M |
| June 30, 2015 | -8.294M |
| March 31, 2015 | 9.511M |
| December 31, 2014 | 16.91M |
| September 30, 2014 | 7.304M |
| June 30, 2014 | 28.26M |
| March 31, 2014 | 10.46M |
| December 31, 2013 | 23.50M |
| September 30, 2013 | 14.91M |
| June 30, 2013 | 8.208M |
| March 31, 2013 | 25.79M |
| December 31, 2012 | -108.27M |
| September 30, 2012 | 19.08M |
| June 30, 2012 | 23.97M |
| March 31, 2012 | 26.18M |
| December 31, 2011 | 17.84M |
| September 30, 2011 | -11.50M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-49.66M
Minimum
Jun 2021
24.46M
Maximum
Mar 2020
0.7014M
Average
2.97M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| Nektar Therapeutics | 17.38M |
| Avid Bioservices Inc | -7.323M |
| Stereotaxis Inc | 0.00 |
| Cara Therapeutics Inc | -30.20M |
| Blueprint Medicines Corp | 78.77M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.24M |
| Cash from Financing (Quarterly) | 0.486M |
| Free Cash Flow | -20.74M |
| Free Cash Flow Per Share (Quarterly) | -0.0358 |
| Free Cash Flow to Equity (Quarterly) | -6.183M |
| Free Cash Flow Yield | -10.74% |